Thrombosis and bleeding in hematological malignancy

Keyphrases

• Hematological Malignancies 100%
• Bleeding 100%
• Thrombosis 100%
• Patients with Hematological Malignancies 100%
• High Risk 33%
• Risk Factors 33%
• Randomized Controlled Trial 33%
• Patients with Cancer 33%
• Anticoagulant Therapy 33%
• Solid Tumors 33%
• Risk Prediction Model 33%
• Patient Demographics 33%
• Bleeding Risk 33%
• Patient-specific 33%
• Specific Risk 33%
• Disease-specific 33%
• Antiplatelet Therapy 33%
• Competing Risks 33%
• Thromboemboli 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Hematologic Malignancy 100%
• Bleeding 100%
• Thrombosis 100%
• Malignant Neoplasm 20%
• Randomized Controlled Trial 20%
• Solid Malignant Neoplasm 20%
• Thromboembolism 20%
• Anticoagulant Agent 20%
• Antiplatelet 20%
• Diseases 20%

Medicine and Dentistry

• Hematologic Malignancy 100%
• Bleeding 100%
• Thrombosis 100%
• Randomized Controlled Trial 20%
• Solid Malignant Neoplasm 20%
• Antiplatelet 20%
• Thromboembolism 20%
• Patient Population 20%
• Antithrombotic 20%
• Diseases 20%